Malek Chamoun
Corporate Officer/Principal chez SUNSHINE BIOPHARMA, INC.
Fortune : 222 000 $ au 31/03/2024
Profil
Malek Chamoun is the founder and current President of Nora Pharma, Inc. which is founded in 2017.
He is currently the Chief Development Officer at Sunshine Biopharma, Inc. where he started in 2024.
Mr. Chamoun received his undergraduate degree from Hautes Etudes Commerciales in 2008.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 28/03/2024 | 3 700 000 ( 3,72% ) | 222 000 $ | 31/03/2024 |
Postes actifs de Malek Chamoun
| Sociétés | Poste | Début |
|---|---|---|
| SUNSHINE BIOPHARMA, INC. | Corporate Officer/Principal | 25/01/2024 |
Nora Pharma, Inc.
 Nora Pharma, Inc. Medical DistributorsDistribution Services Part of Sunshine Biopharma, Inc., Nora Pharma, Inc. is a Canadian company that sells generic drugs. The private company is based in Varennes, Canada. The company was founded in 2017 by Malek Chamoun. Nora Pharma was acquired by Sunshine Biopharma, Inc. on October 20, 2022 for $22.88 million. | Founder | 01/01/2017 |
Formation de Malek Chamoun
| Hautes Etudes Commerciales | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SUNSHINE BIOPHARMA, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Nora Pharma, Inc.
Nora Pharma, Inc. Medical DistributorsDistribution Services Part of Sunshine Biopharma, Inc., Nora Pharma, Inc. is a Canadian company that sells generic drugs. The private company is based in Varennes, Canada. The company was founded in 2017 by Malek Chamoun. Nora Pharma was acquired by Sunshine Biopharma, Inc. on October 20, 2022 for $22.88 million. | Distribution Services |
